Candida auris: The Unprecedented Threat and the Assay That Fights Back

In the midst of an alarming surge in Candida auris cases, the world faces an unprecedented challenge as Candida auris spreads rapidly through healthcare settings, defying conventional treatments and posing a grave threat to vulnerable patients.

In response to this urgent crisis, our cutting-edge Candida auris Simplicity Panel™ stands as a powerful new weapon. This in-vitro multiplex real-time polymerase chain reaction (RT-PCR) assay is meticulously designed to swiftly and accurately identify Candida auris. Its sensitivity and specificity are now more critical than ever, providing researchers with the means to detect and contain the pathogen with unprecedented speed.

Candida auris Mockup-1

Download the Full Product Specifications Document


Candida auris PCR Panel At-a-Glance

  • Identification of critical emerging pathogen, Candida auris
  • Listed by the U.S. CDC as a Nationally Notifiable Condition
  • Facilitate management of laboratory research on healthcare-associated infections
  • Available as a standalone assay or could be added to a custom panel
Candida auris icon

arrow arrow2

  • Candida auris

Have additional questions?

Our team is prepared to answer any questions you may have.